Current stage-Inflammatory breast cancer Posts on Medivizor
Navigation Menu

Current stage-Inflammatory breast cancer Posts on Medivizor

Comparing the long-term effectiveness and safety of trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer

Comparing the long-term effectiveness and safety of trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer

Posted by on Jun 11, 2023 in Breast cancer | 0 comments

In a nutshell The study compared the effectiveness and safety of trastuzumab deruxtecan (TD; Enhertu) with trastuzumab emtansine (TE; Kadcyla) in patients with HER2-positive (HER2+) metastatic breast cancer (BC). The study found that TD was more effective and well-tolerated compared to TE in these patients. Some background HER2+ BC...

Read More

Evaluating the effectiveness of adding targeted therapy to chemotherapy before surgery for inflammatory breast cancer.

Evaluating the effectiveness of adding targeted therapy to chemotherapy before surgery for inflammatory breast cancer.

Posted by on May 30, 2021 in Breast cancer | 0 comments

In a nutshell This study evaluated the effectiveness of adding targeted therapy to chemotherapy before surgery for the treatment of patients with inflammatory breast cancer (IBC). The data showed that adding targeted therapy is more effective than chemotherapy alone for these patients. Some background IBC is a rare and aggressive form of...

Read More

Which is safer for the heart: tamoxifen or letrozole?

Which is safer for the heart: tamoxifen or letrozole?

Posted by on Nov 30, 2020 in Breast cancer | 0 comments

In a nutshell This study compared the safety of two hormonal medications used to treat breast cancer, tamoxifen (Nolvadex) and letrozole (Femara). This study found that tamoxifen was associated with an increased risk of blood clots, while letrozole was associated with an increased risk of angina and heart attacks. Some background Hormone-positive...

Read More

Searching for patients with inflammatory breast cancer to trial a new medication with radiotherapy

Posted by on Jan 31, 2019 in Breast cancer | 0 comments

In a nutshell This trial aims to test the effectiveness of adding olaparib (Lynparza) to radiotherapy for inflammatory breast cancer. The main outcome measured will be how long the patients survive without the disease coming back in its invasive form. The study is being conducted in the United States. The details Inflammatory breast cancer can be...

Read More

The influence of infection on breast cancer recurrence following breast reconstruction

The influence of infection on breast cancer recurrence following breast reconstruction

Posted by on Mar 21, 2016 in Breast cancer | 0 comments

In a nutshell The authors aimed to assess the influence of possible infections following breast reconstruction on the risks of breast cancer recurrence. This study showed that post-operative complications or infections had a significant impact on the rates of breast cancer recurrence. Some background Breast reconstruction surgery is a procedure...

Read More

LDH as an early predictor of cancer survival

Posted by on Feb 8, 2016 in Breast cancer | 14 comments

In a nutshell This study investigated the relationship between lactate dehydrogenase (LDH) levels and cancer-specific survival. Researchers concluded that LDH can be used as an early indicator of cancer outcomes. Some background Early cancer detection methods have significantly improved cancer survival rates. There is increasing evidence to...

Read More

Breast cancer; what are the risks of cancer returning following surgery?

Breast cancer; what are the risks of cancer returning following surgery?

Posted by on Jun 24, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to assess the overall risks of breast cancer recurrence (return of the cancer) following two types of breast cancer surgery. Some background Breast cancer treatments may include surgery; a mastectomy is the removal of the entire breast while breast-conserving surgery is the removal of the breast cancer but not the...

Read More

Treatment guidelines for early breast cancer

Treatment guidelines for early breast cancer

Posted by on Apr 24, 2014 in Breast cancer | 0 comments

In a nutshell This article provides an overview of the new treatment guidelines for early invasive breast cancer as set by the 2013 St. Gallen Consensus. Some background The St. Gallen Consensus of 2011 offered the current guidelines for the treatment of early-stage breast cancers. Recently, an expert panel of 51 physicians and scientists convened...

Read More

Breast cancer risks with hormone replacement therapy

Breast cancer risks with hormone replacement therapy

Posted by on Mar 30, 2014 in Breast cancer | 0 comments

In a nutshell This study evaluated breast cancer risk and outcomes among postmenopausal women using hormone replacement therapy. Some background Progesterone and estrogen are steroid hormones that have a crucial role in female maturation and reproduction processes. The female menstrual cycle, ovulation and pregnancy are only part of the...

Read More

MammaPrint genetic testing for prediction of long-term breast cancer outcomes

Posted by on Feb 24, 2014 in Breast cancer | 0 comments

In a nutshell This study investigated the accuracy of the 70-gene signature (MammaPrint) genomic profiling test in predicting metastasis and long-term outcomes among breast cancer patients. Some background Gene-expression signature tests, such as MammaPrint, were developed in order to assess the biological action, and therefore the aggressiveness,...

Read More
ABOUT USHOW IT WORKSBLOG NEWS PARTNERS CONTACT US PRIVACY POLICY TERMS OF USE
FROM OUR BLOG
LATEST NEWS
CONNECT WITH US
© 2024 Medivizor